Abstract:Malaria is one of the deadliest infectious diseases threatening half of the world population. With the deterioration of the parasiticidal effect of the current antimalarials, novel approaches such as screening of more specific inhibitors and targeted delivery of drugs have been under intensive research. Herein, we prepare hollow mesoporous ferrite nanoparticles (HMFNs) of 200 nm with ferromagnetic properties using a one-pot hydrothermal reaction. A magnetically targeted drug-delivery system coloaded with artemisinin in the inner magnetite shell and heparin on the outer mesoporous shell (@HEP) is developed. Specific targeting of the magnetic nanoparticles to the parasite-infected erythrocytes is achieved by the attraction between the HMFNs and hemozoin (paramagnetic), a vital metabolite of plasmodium in the erythrocytic stage. With the hemozoin production reaching the maximum during the schizont period of the parasite, @HEPs are adsorbed to the infected red blood cells (iRBCs), which not only interferes with the release of merozoites but also significantly enhances the inhibitory efficacy due to the increased local concentration of artemisinin. Subsequently, the heparin coated on the surface of the nanoparticles can efficiently interfere with the invasion of freshly released merozoites to new RBCs through the specific interaction between the parasite-derived ligands and heparin, which further increases the inhibitory effect on malaria. As a cluster of heparin, heparin-coated nanoparticles provide stronger blocking capability than free heparin, resulting from multivalent interactions with surface receptors on merozoite. Thus, we have developed a HMFN-based delivery system with considerable antimalarial efficacy, which is a promising platform for treatment against malaria.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c20070?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c20070</a>.Flow cytometry analysis of parasitemia after the treatment by free heparin, free artemisinin, and various drug-delivery systems under different conditions (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c20070/suppl_file/am0c20070_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A magnetically modified black phosphorus nanosheet-based heparin delivery platform for preventing DVT accurately.

Facile immobilization of heparin on bioabsorbable iron via mussel adhesive protein (MAPs)

Combined drug anti-deep vein thrombosis therapy based on platelet membrane biomimetic targeting nanotechnology

Development of substrate-independent heparin coating to mitigate surface-induced thrombogenesis: efficacy and mechanism

Mussel-inspired one-step adherent coating rich in amine groups for covalent immobilization of heparin: hemocompatibility, growth behaviors of vascular cells, and tissue response

Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy

Human hair derived uPA loaded capsules with dual near-infrared (I and II biowindows) laser responsive capabilities for multi-effective thrombolysis therapy

Novel Thrombo-Resistant Coating Based on Iron-Polysaccharide Complex Multilayers

Novel pH-responsive and mucoadhesive chitosan-based nanoparticles for oral delivery of low molecular weight heparin with enhanced bioavailability and anticoagulant effect

Design and fabrication of r-hirudin loaded dissolving microneedle patch for minimally invasive and long-term treatment of thromboembolic disease

Preparation and Evaluation of a Self-Nanoemulsifying Drug Delivery System Loaded with Heparin Phospholipid Complex

Swarming magnetic nanorobots bio-interfaced by heparinoid-polymer brushes for in vivo safe synergistic thrombolysis

Enhanced Antimalarial Efficacy Obtained by Targeted Delivery of Artemisinin in Heparin-Coated Magnetic Hollow Mesoporous Nanoparticles

Novel hollow microcapsules based on iron-heparin complex multilayers.

Clot structure-based physical-matching design of platelet cloaking nano-delivery system facilitates specific arteriovenous thrombolysis

Erythrocyte‐membrane‐camouflaged magnetic nanocapsules with photothermal/magnetothermal effects for thrombolysis

Heparin-engineered mesoporous iron metal-organic framework nanoparticles: toward stealth drug nanocarriers

Polydopamine-heparin Complex Reinforced Antithrombotic and Antimicrobial Activities of Heparinized Hydrogels for Biomedical Applications

Enhanced-permeability delivery system for hydroxyl radical-responsive NIR-II fluorescence-monitored thrombolytic therapy

Multi-enzyme mimetic iridium nanozymes-based thrombus microenvironment-modulated nanoplatform for enhanced thrombolytic therapy